Ho JG, Schmidt D, Lowinus T, Ryoo J, et al. Targeting MDM2 enhances anti-leukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation. Blood 2022 Jul 19. pii: 485955. doi: 10.1182/blood.2022016082.
PMID: 35853161